Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA Splicing01:32

RNA Splicing

56.6K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.6K
Alternative RNA Splicing02:18

Alternative RNA Splicing

21.5K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.5K
Pre-mRNA Processing: RNA Splicing01:36

Pre-mRNA Processing: RNA Splicing

5.3K
5.3K
Chromatin Structure and RNA Splicing02:41

Chromatin Structure and RNA Splicing

2.8K
2.8K
Exon Recombination02:32

Exon Recombination

3.6K
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon...
3.6K
Pre-mRNA Processing: Modification of pre-mRNA Ends01:35

Pre-mRNA Processing: Modification of pre-mRNA Ends

9.7K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
9.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intron location and sequence modulate gene expression in Yarrowia lipolytica.

Nucleic acids research·2026
Same author

Genetic screening of children for familial hypercholesterolaemia: the VRONI study.

European heart journal·2026
Same author

RNA Sequencing Resolves Cryptic Pathogenic Variants in Mitochondrial Disease.

Annals of clinical and translational neurology·2026
Same author

Non-destructive transcriptomics via vesicular export.

Nature communications·2026
Same author

Clinical and Genotypic Spectrum of Twinkle-Related Disorders: Insights From a Multinational Cohort Study.

Neurology·2026
Same author

Author Correction: The Solve-RD Solvathons as a pan-European interdisciplinary collaboration to diagnose patients with rare disease.

Nature genetics·2026
Same journal

Mutational scanning reveals substrate-assisted autoregulation of the WNT destruction complex.

Nature genetics·2026
Same journal

Spatial transcriptomic analyses highlight distinct erythroid niches in mice and humans.

Nature genetics·2026
Same journal

Building up pangenome analysis block by block.

Nature genetics·2026
Same journal

Mutations in splicing factor gene U2AF1 rescue defective oncogene splicing in KRAS-mutant cancers.

Nature genetics·2026
Same journal

Assessing the effect of immune surveillance on clonal expansions in the blood.

Nature genetics·2026
Same journal

Improved heritability partitioning and enrichment analyses using summary statistics with graphREML.

Nature genetics·2026
See all related articles

Related Experiment Video

Updated: Jul 31, 2025

Identification of Alternative Splicing and Polyadenylation in RNA-seq Data
08:35

Identification of Alternative Splicing and Polyadenylation in RNA-seq Data

Published on: June 24, 2021

5.7K

Aberrant splicing prediction across human tissues.

Nils Wagner1,2, Muhammed H Çelik1,3, Florian R Hölzlwimmer1

  • 1School of Computation, Information and Technology, Technical University of Munich, Garching, Germany.

Nature Genetics
|May 4, 2023
PubMed
Summary
This summary is machine-generated.

This study improves the detection of aberrant splicing, a cause of genetic disorders, by integrating RNA data. The new AbSplice model significantly enhances precision in identifying disease-causing variants across human tissues.

More Related Videos

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.0K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

13.8K

Related Experiment Videos

Last Updated: Jul 31, 2025

Identification of Alternative Splicing and Polyadenylation in RNA-seq Data
08:35

Identification of Alternative Splicing and Polyadenylation in RNA-seq Data

Published on: June 24, 2021

5.7K
Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.0K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

13.8K

Area of Science:

  • Genomics
  • Molecular Biology
  • Bioinformatics

Background:

  • Aberrant splicing is a key driver of genetic disorders.
  • Current detection methods are limited to accessible tissues.
  • DNA-based models for predicting splicing effects are limited in tissue-specific accuracy.

Purpose of the Study:

  • To develop a more accurate method for detecting tissue-specific aberrant splicing.
  • To improve the identification of noncoding loss-of-function variants.
  • To enhance genetic diagnostics by assessing splicing impacts.

Main Methods:

  • Generated an aberrant splicing benchmark dataset from 8.8 million rare variants across 49 human tissues (GTEx).
  • Mapped and quantified tissue-specific splice site usage and modeled isoform competition.
  • Integrated RNA-sequencing data from accessible tissues into the AbSplice model.

Main Results:

  • State-of-the-art DNA-based models achieved only 12% precision at 20% recall for tissue-specific splicing.
  • The developed method increased precision threefold by analyzing splice site usage and isoform competition.
  • The AbSplice model, integrating RNA data, reached 60% precision, validated in independent cohorts.

Conclusions:

  • The AbSplice model significantly improves the precision of aberrant splicing detection across diverse human tissues.
  • This advancement aids in identifying noncoding loss-of-function variants and enhances genetic diagnostics.
  • The findings offer a more comprehensive approach to understanding splicing defects in genetic disorders.